Golden has been acquired by ComplyAdvantage.Read about it here ⟶
User profile

Tao Le

Medical educator, author, physician.
Joined May 2019
2
Contributions
ContributionsActivity
Beyond MeatBeyond Meat was edited byTao Le profile picture
Tao Le
May 1, 2019 7:08 pm
Article  (+8/-7 characters)

In April 2019, ahead of going public, Beyond Meat increased the size of its shares and has plans to offer 9.5 million shares at $23-25. The company applied to list on Nasdaq under the ticker symbol BYND and is expected to begin trading May 2, 2019. Book-running mangersmanagers for the offering include Goldman Sachs & Co. LLC, J.P. Morgan and Credit Suisse as lead managers as well as BofA Merrill Lynch and Jefferies and William Blair as co-manager.

ImmunotherapyImmunotherapy was edited byTao Le profile picture
Tao Le
May 1, 2019 6:55 pm
Article  (+1 videos) (+116 characters)

PD-1 inhibitors include pembrolizumab and nivolumab.

PD-L1 inhibitors include atezolizumab, avelumab, and durvalumab.